EDAP TMS S.A. FOCL
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +27.05%
- 1 year
- +92.63%
- Open
- 4.30
- Prev close
- 4.17
- Mkt cap
- 197.37M
- Vol
- 66.14K
- Avg vol
- 109.55K
- EPS
- -1.39
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.10
- High
- 4.41
News
1 week ago globenewswire.com
FocalTherics™ to Announce Third Quarter 2026 Financial Results on November 5, 2026
Company to host conference call and webcast on Thursday, November 5 at 4:30 p.m. ET Company to host conference call and webcast on Thursday, November 5 at 4:30 p.m. ET
2 months ago globenewswire.com
FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference
FocalTherics ™ to Present at the H.C. Wain w right 28 th Annual Global Investment Conference Company to Present and Host 1x1 Investor Meetings on T uesday and Wednesday, September 15 th -16 th , 2026…
-
2 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Edap TMS, Maintains $10 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Edap TMS (NASDAQ:FOCL) with a Buy and maintains $10 price target.
2 months ago defenseworld.net
Analysts Set FocalTherics (NASDAQ:FOCL) Target Price at $9.00
FocalTherics (NASDAQ: FOCL - Get Free Report) has earned a consensus recommendation of "Hold" from the five analysts that are covering the stock, Marketbeat reports. One research analyst has rated…
2 months ago seekingalpha.com
EDAP TMS S.A. (FOCL) Q2 2026 Earnings Call Transcript
EDAP TMS S.A. (FOCL) Q2 2026 Earnings Call Transcript
2 months ago marketbeat.com
FocalTherics Q2 Earnings Call Highlights
FocalTherics NASDAQ: FOCL reported second-quarter HIFU revenue of $13.2 million, up 39% from $9.5 million a year earlier, as the company continued to expand sales of its Focal One high-intensity…
2 months ago benzinga.com
Edap TMS Q2 2026 Earnings Call: Complete Transcript
Edap TMS (NASDAQ:FOCL) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by…
-
2 months ago benzinga.com
FocalTherics Q2 EPS $(0.38) Misses $(0.20) Estimate, Sales $13.200M Miss $14.440M Estimate
FocalTherics (NASDAQ:FOCL) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.20) by 90 percent. This is a 123.53 percent decrease over losses of…
2 months ago globenewswire.com
FocalTherics™ Reports Second Quarter 2026 Financial Results
FocalTherics™ Reports Second Quarter 2026 Financial Results 39% Revenue Increase and 47% Growth in U.S. Procedures AUSTIN, Texas, Aug. 13, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) (the…
2 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Bone Biologics (NASDAQ:BBLG) stock moved upwards by 17.7% to $1.07 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6 million. Definium Therapeutics
2 months ago globenewswire.com
FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares
FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares AUSTIN, Texas and LYON, France, Aug. 11, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (NASDAQ: FOCL) (the “Company”), a…
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 44.4% to $1.56 during Tuesday's after-market session. The company's market cap stands at $4.5 million. As per the news, the Q2…
-
2 months ago benzinga.com
FocalTherics Reports Preliminary Q2 Sales Of $12.7M-$13.2M, Up 34%-39% Year-On-Year
During the second quarter of 2026, the Extracorporeal Shock Wave Lithotripsy (ESWL) and Distribution segments met the criteria to be classified as held for sale under ASC 205-20, Presentation of…
2 months ago globenewswire.com
FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026
FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026 AUSTIN, Texas, Aug. 11, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) (the “Company”), a global leader in…
-
2 months ago benzinga.com
FocalTherics Announces Underwritten Public Offering Of ADSs
The Company intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the ADSs sold in the Offering on the same terms and conditions. The terms of the ADSs to be issued…
2 months ago globenewswire.com
FocalTherics™ Announces Proposed Public Offering of American Depositary Shares
FocalTherics™ Announces Proposed Public Offering of American Depositary Shares AUSTIN, Texas and LYON, France, Aug. 11, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (NASDAQ: FOCL) (the “Company”), a global…
2 months ago zacks.com
FocalTherics (FOCL) Surges 6.2%: Is This an Indication of Further Gains?
FocalTherics (FOCL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down…
3 months ago globenewswire.com
FocalTherics™ to Announce Second Quarter 2026 Financial Results on August 13, 2026
FocalTherics to Announce Second Quarter 2026 Financial Results on August 13, 2026 Company to host conference call and webcast on Thursday, August 13 at 4:30 p. m. EDT AUSTIN, Texas, July 30, 2026…
-
4 months ago benzinga.com
FocalTherics Launches First European Commercial Endometriosis Focal One Program With Treatment Of Initial Patients In Toulouse, France
The hospital launched their endometriosis Focal One program following the acquisition of the system with the intention of utilizing it for treating both deep infiltrating endometriosis and prostate…
4 months ago globenewswire.com
FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients
FocalTherics Announces Successful Launch of First Commercial Endometriosis Focal One Program in Europe with Treatment of Initial Patients AUSTIN, Texas, June 30, 2026 (GLOBE NEWSWIRE) -- FocalTherics…
-
4 months ago benzinga.com
FocalTherics Expanding Focal One Robotic HIFU Access Under Signed Agreement With MellingMedical To Federal Healthcare Providers
FocalTherics (Nasdaq: FOCL) (the "Company"), the global leader in robotic focal therapy, today announced that it has entered into an agreement with MellingMedical, a leading SBA-Verified…
4 months ago globenewswire.com
FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical
FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical AUSTIN, Texas, June 16, 2026 (GLOBE NEWSWIRE) -- FocalTherics (Nasdaq:…
-
5 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on FocalTherics, Maintains $10 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates FocalTherics (NASDAQ:FOCL) with a Buy and maintains $10 price target.